Copart is not a good buy right now for a beginner long-term investor with fresh capital. The stock has no strong proprietary buy signal, fundamentals are weakening, analyst sentiment is turning cautious, and the near-term pattern points to limited upside with downside risk. If you already own it, holding is reasonable, but I would not add new money here based on the current data.
CPRT is trading at 34.105, just above the pivot at 33.437 and near first resistance at 34.022 to 34.383. MACD histogram is positive and expanding, which supports short-term momentum, but RSI_6 at 70.983 is stretched and moving averages are converging, signaling a less convincing trend. The setup is more neutral than bullish, and the stock trend model suggests roughly flat to slightly negative performance over the next week to month.

["MACD histogram is positive and expanding, indicating short-term upward momentum.", "Options positioning leans bullish with open interest put-call ratio at 0.42 and volume put-call ratio at 0.61.", "Baird still has an Outperform rating and said the stock is looking more attractive after the earnings shortfall."]
["No news in the recent week, so there is no fresh event-driven catalyst.", "Q2 financials weakened: revenue down 3.58% YoY, net income down 9.47% YoY, EPS down 10.00% YoY, and gross margin down 2.74% YoY.", "JPMorgan cut its target to $34 from $45 and turned more cautious on fee-rate pressure.", "Barclays cut its target to $32 and keeps an Underweight rating after the fiscal Q2 miss.", "Hedge funds and insiders are neutral, with no meaningful positive accumulation signal.", "Congress trading is balanced, with one purchase and one sale, offering no clear bullish cue.", "The stock trend model points to about -7.43% over the next month."]
In fiscal Q2 2026, Copart showed weaker growth trends. Revenue fell to $1.1217B, down 3.58% YoY. Net income declined 9.47% YoY to $350.7M, EPS dropped 10.00% YoY to $0.36, and gross margin compressed to 43.94%, down 2.74% YoY. For a long-term beginner investor, this is not the kind of accelerating quarter that supports an aggressive new buy.
Analyst sentiment has deteriorated recently. JPMorgan lowered its target to $34 from $45 and kept Neutral, Barclays cut to $32 from $33 and kept Underweight, and only Baird remained constructive with an Outperform while lowering its target to $48 from $52. Overall, Wall Street pros are leaning cautious to mixed, with more downside-oriented revisions than bullish ones.